Today's focus

[Dengyun Co., Ltd.: Short-term transaction with the spouse of Chairman of the Supervisory Board Ye Zhi]

Dengyun Co., Ltd. announced that the company recently received the “Information Note and Apology Letter on Trading Dengyun Shares” from Ms. Ye Zhi, Chairman of the Supervisory Board. It was learned that Ye Zhi's spouse, Yi Chang, traded the company's shares between April 10, 2024 and April 11, 2024, constituting a short-term transaction. Yi Chang's revenue from the above short-term transactions was 160 yuan. Ye Zhi was unaware of this transaction in advance, and Yi Chang did not seek the opinions and mutual discussions of Ms. Ye Zhi on stock trading matters. There was no situation where the company's shares were traded for profit due to receiving insider information, nor was there any purpose of using short-term trading to seek profit. Yi Chang was keenly aware of the negative impact of this illegal short-term transaction on the company and the market, and apologized to the company's investors.

[Carmel Packaging: Net profit for the first quarter increased 75.28% — 127.66% year on year]

Jiamei Packaging released its performance forecast for the first quarter of 2024. The net profit for the first quarter is expected to be 41.752 million yuan to 54.2234 million yuan, an increase of 75.28% to 127.66% over the previous year. The company released its 2023 annual performance report on the same day, and achieved net profit of 154 million yuan in 2023, an increase of 805.71% over the previous year.

[Cathay Biotech: Net profit increased 63.65% to 100.20% year-on-year in the first quarter]

Kaisai Biotech announced its performance forecast for the first quarter of 2024. It is expected to achieve revenue of 650 million yuan to 720 million yuan in the first quarter, an increase of 28.60% to 42.45% over the previous year. It is expected to achieve net profit of 94 million yuan to 115 million yuan in the first quarter, an increase of 63.65% to 100.20% year-on-year. During the reporting period, due to the recovery in downstream demand, the company's long-chain binary acid sales volume and sales revenue increased sharply compared to the same period last year.

[Xinlian integration: plans to buy back shares at 200 million yuan to 400 million yuan]

Xinlian Integration announced that the company plans to use its own funds to repurchase shares through centralized bidding transactions. The repurchase amount is not less than 200 million yuan (inclusive) and no more than 400 million yuan (inclusive). The repurchase price of shares shall not exceed 7 yuan/share (inclusive). The repurchase of shares is for share incentives and/or employee stock ownership plans.

[Xiangcai Co., Ltd.: Plans to repurchase shares for 80 million yuan to 160 million yuan]

Xiangcai Co., Ltd. announced that the company plans to use its own funds to repurchase shares through centralized bidding transactions for employee stock ownership plans or equity incentives. The total capital for the repurchase of shares is not less than RMB 8 million and not more than RMB 160 million, and the repurchase price is not more than RMB 1,004 per share (inclusive).

Reduce & increase holdings

[TD Optics: The actual controller's concerted action plans to reduce the company's shares by no more than 1% in total]

TD Optics announced that the actual controller, Hu Huiling, the shareholder of the company, holds 28.08 million shares of the Company, accounting for 4.48% of the Company's total share capital; the actual controller, Hu Haoheng, the shareholder and director of the Company, holds approximately 10.184,400 shares of the Company, accounting for 1.63% of the Company's total share capital. Hu Huiling and Hu Haoheng plan to reduce their holdings through centralized bidding transactions and/or bulk transactions. The total number of shares reduced by the company will not exceed 624.60 shares, that is, no more than 1.00% of the company's total share capital.

Cooperation & Approval

[Novi Zane: Subsidiary signs strategic cooperation agreement with Yufang Medical]

Novi Zan announced that its wholly-owned subsidiary Nanjing Novi Zan Medical Technology Co., Ltd. recently signed a “Strategic Cooperation Agreement” with Shanghai Yufang Medical Technology (Group) Co., Ltd. (“Yufang Medical”) on strategic cooperation between the two parties in screening and testing business. The two sides will rely on their respective industry positions and resource advantages, follow the health concept of “prevention is greater than treatment”, and strengthen cooperation on Party A's Alzheimer's disease (AD) blood testing products on the premise that they meet their respective compliance operations and market strategic goals.

[New industry: the company's products obtained US FDA 510 (k) approval]

New industry announcement. Recently, the company received a notice from the US Food and Drug Administration (hereinafter referred to as “FDA”). The company's fully automatic chemiluminescence immunoassay analyzer MAGLUMI X3 and 25-hydroxyvitamin D determination kit (chemiluminescence immunoassay) products were approved by the US FDA 510 (k).

Operation & Performance

[Yichang Technology: Net profit increased 401.2% year-on-year in the first quarter]

Yichang Technology disclosed the first quarter report. In the first quarter of 2024, it achieved operating income of 572 million yuan, an increase of 12.37%; net profit to mother of 53.94 million yuan, an increase of 401.2% over the previous year; and basic earnings per share of 0.14 yuan.

[Lianke Technology: Net profit of 55,145,900 yuan in the first quarter increased by 214.55% year-on-year]

Lianke Technology disclosed its report for the first quarter of 2024. The first quarter achieved operating income of 520 million yuan, an increase of 12.33%; net profit of 55,1459 million yuan, an increase of 214.55%; and basic earnings per share of 0.28 yuan.

[Shenzhen Airport: Net profit of 82.72 million yuan to 113 million yuan in the first quarter]

Shenzhen Airport released a performance forecast. The net profit for the first quarter of 2024 is expected to be 82.72 million yuan to 113 million yuan, reversing the loss over the previous year. During the reporting period, as the civil aviation market continued to pick up, the company's main business development trend was good. Passenger throughput increased 36% year on year, and flight take-off and landing times increased 21% year on year, leading to a year-on-year increase in the company's revenue and year-on-year increase in business performance.

[Shaanxi SDIC A: Net profit increased 10.03% year-on-year in the first quarter]

Shaanxi SDIC A released a quick performance report. In the first quarter of 2024, the company achieved operating income of 717 million yuan, an increase of 18.80% over the previous year; net profit to mother of 368 million yuan, an increase of 10.03% over the previous year; and basic earnings per share of 0.07 yuan. During the reporting period, the main trust business of the company operated smoothly and achieved new results in transformation. The scale of managed trusts increased to 555.927 billion yuan, which was steady and safe, and the quality and efficiency improved. At the same time, the company's own business operations are effective and the benefits are good.

[Guangdong Construction Engineering: Net profit in 2023 fell 10.27% year on year, and plans to pay 10 1.55 yuan]

Guangdong Construction Engineering disclosed its annual report. In 2023, it achieved operating income of 80.863 billion yuan, a year-on-year decrease of 2.07%; net profit to mother was 1,534 billion yuan, a year-on-year decrease of 10.27%; and basic earnings per share were 0.43 yuan. It is proposed to distribute a cash dividend of 1.55 yuan (tax included) for every 10 shares to all shareholders.

[Dongpeng Beverage: Net profit increased 41.6% year-on-year in 2023, and plans to pay 10 yuan to pay 25 yuan]

Dongpeng Drinks released its annual report. In 2023, it achieved operating income of 11.263 billion yuan, an increase of 32.42% year on year; net profit to mother of 2,040 billion yuan, an increase of 41.60% year on year; and basic earnings per share of 5.10 yuan. It is proposed to pay 25 yuan (tax included) for every 10 shares to all shareholders. In 2023, Dongpeng Special Drink's sales revenue was 10.336 billion yuan, accounting for 91.87%.

[Chengdu HuaWei: Net profit increased 10.61% year-on-year in 2023, and plans to pay 10 1.12 yuan]

Chengdu HuaWei released its annual report. In 2023, it achieved operating income of 926 million yuan, an increase of 9.64% year on year; realized net profit of 311 million yuan, an increase of 10.61% year on year; and basic earnings per share of 0.57 yuan. It is proposed to distribute a cash dividend of 1.12 yuan (tax included) for every 10 shares.

[Zhongke Star Map: Net profit increased by 41.1% year on year in 2023, plan to turn 10 to 4.9 to 1.92 yuan]

According to the annual report, Zhongke Star Map revealed that in 2023, it achieved operating income of 2,516 billion yuan, an increase of 59.54% year on year; net profit of 343 million yuan, up 41.1% year on year; and basic earnings per share of 0.94 yuan. It is proposed to distribute a cash dividend of 1.92 yuan (tax included) to all shareholders for every 10 shares, while using capital reserve to increase 4.9 shares for every 10 shares.

[Crystal Integration: 2023 net profit of 212 million yuan decreased by 93.05% year-on-year]

According to the announcement of Jinghe Integrated, in 2023, it achieved operating income of about 7.244 billion yuan, a year-on-year decrease of 27.93%; realized net profit of about 212 million yuan, a year-on-year decrease of 93.05%; and basic earnings per share of 0.12 yuan. During the reporting period, the boom in the semiconductor industry declined, and overall market demand slowed.

[Rockchip: Net profit reduced by 54.65% to 135 million yuan in 2023, plans to pay 10 to 2 yuan]

Rockchip announced that in 2023, it achieved operating income of 2,135 billion yuan, a year-on-year increase of 5.17%; net profit attributable to shareholders of listed companies was 135 million yuan, a year-on-year decrease of 54.65%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 126 million yuan, a year-on-year decrease of 26.78%; and basic earnings per share of 0.32 yuan. It is proposed to distribute a cash dividend of 2.00 yuan (tax included) for every 10 shares to all shareholders. During the reporting period, the company's income from changes in fair value from foreign investment, such as government subsidies, etc., was drastically reduced by about 116 million yuan compared to the previous year; as well as rising costs of some wafers, intense market competition and pressure on product sales prices led to a year-on-year decline in gross profit.

[Xianda Stock Performance Report: Net loss of 98.2819 million yuan in 2023]

Xianda Co., Ltd. released a quick performance report. In 2023, it achieved total operating income of 2,482 billion yuan, a year-on-year decrease of 20.58%; a net profit loss of 98.2819 million yuan, and a profit of 381 million yuan for the same period last year, turning a year-on-year loss. During the reporting period, pesticide prices continued to decline, sales prices of the company's main products fell to varying degrees, and losses occurred on some products, leading to a sharp decline in the company's annual performance.

[Shanghai Airport: Passenger throughput at Pudong International Airport increased 69.5% year-on-year in March]

Shanghai Airport announced that in March, the company's Pudong International Airport had a passenger throughput of 6.102,800 passengers, an increase of 69.5% year on year; cargo and mail throughput was 32.42 million tons, up 9.49% year on year. The company's Hongqiao International Airport has a passenger throughput of 4,044,900 passengers, an increase of 19.04% over the previous year; the cargo and mail throughput was 34,000 tons, an increase of 45.28% over the previous year.

[Huatong Co., Ltd.: March pig sales revenue of 402 million yuan, up 32.32% year on month]

Huatong Co., Ltd. announced that in March, the company sold about 236,400 pigs, a change of 28.07% month-on-month and a year-on-year change of 25.89%. In March, the company's pig sales revenue was about 402 million yuan, a change of 32.32% month-on-month and a year-on-year change of 22.89%. In March, the average sales price of commercial pigs was 14.70 yuan/kg, up 2.80% from February 2024. The main reason for the month-on-month change in pig sales revenue in March was due to an increase in sales volume.

[Tiandi Source: Contract sales amount of 1,555 billion yuan in the first quarter decreased by 40.52% year-on-year]

Tiandi Source announced that from January to March 2024, the company had no new real estate land reserves; the company had no new construction area, achieving a completed area of 25,500 square meters. From January to March, the company achieved a contract sales area of 71,200 square meters, a year-on-year decrease of 55.75%; achieved equity contract sales area of 61,900 square meters, a year-on-year decrease of 45.46%. The realized contract sales amount was 1,555 billion yuan, a year-on-year decrease of 40.52%; the realized equity contract sales amount was 1,412 billion yuan, a year-on-year decrease of 31.04%.

other

[Xin'an Century: The controlling shareholders and actual controllers of the company voluntarily promise not to reduce the company's shares within 12 months]

According to Xin'an Century's announcement, Li Wei, Wang Yixin, and Ding Chun, the controlling shareholders and actual controllers of the company each voluntarily promised not to reduce their direct holdings of the company in any way for 12 months from April 22, 2024.

[Dengyun Co., Ltd.: Plans to acquire shares of Speed Technology Controlling Company and suspends trading]

Dengyun Co., Ltd. announced that the company is planning to issue shares and pay cash to acquire a controlling interest in Speed Technology Co., Ltd. (“Speed Technology”). Trading of the company's shares has been suspended since the opening of the market on April 15 due to uncertainties about related matters.

[Skyrim Co., Ltd.: Subsidiary Xinte Chemical temporarily suspends production to improve quality and expand production]

Tianji Co., Ltd. announced that its wholly-owned subsidiary Changshu Xinte Chemical Co., Ltd. (“Xinte Chemical” for short) will temporarily stop production from April 15, 2024 to carry out technical improvements and expansion of production. The expected shutdown period is until the end of May 2024. The specific resumption time of production will be determined depending on the transformation of the project.

[Renhe Pharmaceutical: Received 584.354 million yuan in government subsidies]

Renhe Pharmaceutical announced that recently, the company received 584.354 million yuan in corporate support funds related to revenue, accounting for 10.17% of the company's 2022 audited net profit attributable to shareholders of listed companies.

[Daye Intelligence: Stop issuing shares to specific targets]

Daye Intelligence announced that after comprehensive consideration of many factors such as current capital market policy changes, company development plans and market financing environment, and after full communication and careful analysis by all parties concerned, the company decided to terminate the issuance of A-shares to specific targets. On the same day, Daye Intelligence released its report for the first quarter of 2024. It achieved net profit of 5.7864 million yuan in the first quarter, reversing losses over the previous year.